New Reforms to Prescription Drug Pricing in the US: Opportunities and Challenges

JAMA. 2022 Sep 20;328(11):1041-1042. doi: 10.1001/jama.2022.15268.

Authors

Thomas J Hwang^{1

2}, Aaron S Kesselheim¹, Benjamin N Rome¹

Affiliations

¹ Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
² Division of Urological Surgery, Brigham and Women's Hospital, Boston, Massachusetts.

PMID: 35984652
DOI: 10.1001/jama.2022.15268

No abstract available

MeSH terms

Costs and Cost Analysis / economics
Drug Costs*
Health Care Reform* / economics
Prescription Drugs* / economics
Prescriptions / economics
United States

Substances

Prescription Drugs